Back
PTC Therapeutics Stock Predictions
Buy
55
PTCT
PTC Therapeutics
Last Price:
41.85
Seasonality Move:
12.84%
7 Day Trial
ALL ACCESS PASS
$
7
PTC Therapeutics Stock Forecast
- Over the next 52 weeks, PTC Therapeutics has on average historically risen by 36% based on the past 8 years of stock performance.
- PTC Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
-
Is PTC Therapeutics Stock Undervalued?
The current PTC Therapeutics [PTCT] share price is $41.85. The Score for PTCT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal. - PTCT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will PTC Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, PTC Therapeutics has on average historically risen by 36% based on the past 8 years of stock performance.
PTC Therapeutics Stock Rating
Buy
55
PTC Therapeutics (PTCT)
is a Buy
Is PTC Therapeutics overpriced?
- PTC Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
PTC Therapeutics Stock Price History
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
ptcbio.com
52-Week Data
52-Week High:
45.80
52-Week Low:
25.01
Prediction Charts
Market Cap:
2.99B
Price in USD:
41.85
Volume:
512.54K
Beta:
0.80
Technical Analysis
SMA50:
33.06
SMA100:
35.94
SMA200:
37.48
52-Wk Change:
-4.36%
Stock Predictions
-
Is PTC Therapeutics stock public?
Yes, PTC Therapeutics is a publicly traded company. -
What is the PTC Therapeutics stock quote today?
The PTC Therapeutics stock price isĀ 41.85 USD today. -
How to buy PTC Therapeutics stock online?
You can buy PTC Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-13 | 26.31 | 25.60 | 26.39 | 25.44 |
Jun-14 | 25.71 | 25.66 | 25.86 | 25.08 |
Jun-15 | 25.87 | 26.19 | 26.55 | 25.44 |
Jun-16 | 25.45 | 26.26 | 27.13 | 25.01 |
Jun-17 | 27.09 | 28.41 | 29.82 | 27.09 |
Jun-21 | 33.40 | 34.07 | 34.61 | 31.36 |
Jun-22 | 33.45 | 36.02 | 37.25 | 33.45 |
Jun-23 | 36.52 | 40.11 | 40.17 | 36.52 |
Jun-24 | 40.20 | 40.22 | 40.80 | 37.64 |
Jun-27 | 40.48 | 40.05 | 40.92 | 39.51 |
Jun-28 | 39.93 | 39.94 | 40.59 | 39.38 |
Jun-29 | 39.81 | 40.40 | 40.78 | 39.42 |
Jun-30 | 40.07 | 40.06 | 40.68 | 39.79 |
Jul-1 | 40.36 | 41.85 | 42.34 | 40.00 |
PTC Therapeutics Earnings
PTC Therapeutics Earnings Report: Per Share PTC Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
PTC Therapeutics Forecast Revenue Growth
PTC Therapeutics Stock Analysis: Historical quarterly revenues per share for PTC Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and an increase next year of $1.41 per share.
* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.